Recall archive / FDA company announcement

Baxter: Cefazolin in Dextrose Injection — FDA announcement Jul 24, 2026

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jul 24, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Cefazolin in Dextrose Injection
Reason: Particulate matter (cardboard) found in the solution.
Classification: Not supplied
Recalling firm: Baxter International Inc.
Quantity: Not supplied
Agency-reported status: Company recall announcement
Source record identifier: 0a7939a9c73e79f8

Open the official record

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.; The affected lots can be identified by locating the lot number and expiration date on the front of the product package and the label attached to the carton, as shown in the images below.; Product Code \| Product Description \| Lot Number \| Expiration Date \| NDC Number; 2G3508 \| Cefazolin in Dextrose Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix \| LD175708 \| 14-Feb-2027 \| 0338-3508-41

Label field

Details supplied by the agency

Lot, code or applicability

July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.; The affected lots can be identified by locating the lot number and expiration date on the front of the product package and the label attached to the carton, as shown in the images below.; Product Code | Product Description | Lot Number | Expiration Date | NDC Number; 2G3508 | Cefazolin in Dextrose Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix | LD175708 | 14-Feb-2027 | 0338-3508-41

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
Product Code	Product Description	Lot Number	Expiration Date	NDC Number
2G3508	Cefazolin in Dextrose Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix	LD175708	14-Feb-2027	0338-3508-41

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date: Jul 24, 2026
Company announcement date: Jul 24, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.